Product Wiki · Recalls · U.S. FDA — Device Enforcement

Recall Z-1283-2024 — LVP software of the Ivenix Infusion System (IIS); LVP-SW-0004

U.S. FDA — Device Enforcement · United States · 2023-05-10 · Class II

AI-assisted, human-edited — this page is drafted with AI from public-source data, then reviewed before publication. How we use AI →
Agency
U.S. FDA — Device Enforcement
Recall identifier
Z-1283-2024
Date of alert
2023-05-10
Country / jurisdiction
United States
Risk level
Class II
Risk type
recall
Brand
Fresenius Kabi USA, LLC
Product category
device
Product type
Devices
Barcode (EAN/GTIN)
00811505030122
Reported risk: Retroactively reported corrections from 2023: 1) A software defect may cause an incorrect (Fail-Stop) alarm when an administration set is loaded or coupled while the pump is executing the power-up sequence. May lead to delay in therapy. 2) Alert is not annunciated informing the clinician that the bolus cannot be delivered when the entered bolus dose exceeds the Care Profile Hard Rate Max limit and Rapid Bolus is selected. May lead to over infusion. Both issues were resolved in all fielded product in software version 5.8.0, which was installed in affected units May thru August 2023.
Primary source: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.